Brief: Janone Selects Regulatory Partner For Phase 2B Trial As Investigational Plan Is Prepared For FDA Filing
June 22 (Reuters) - Janone Inc JAN.O :
* JANONE SELECTS REGULATORY PARTNER FOR PHASE 2B TRIAL AS
INVESTIGATIONAL PLAN IS PREPARED FOR FDA FILING
* JANONE - ANNOUNCED SELECTION OF AVANIA AS REGULATORY
PARTNER IN
UPCOMING PLANNED PHASE 2B TRIAL OF LEAD PRODUCT CANDIDATE JAN101
Source text for Eikon: urn:newsml:reuters.com:*:nPn3LMt7ja
Further company coverage: JAN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AI Financial
See all newsBrief: ALT5 Sigma Corporation Restores Compliance With Nasdaq Periodic Filing Requirements
Brief: Alt5 Sigma Expects To File Its Quarterly Report On Form 10-Q
Media: Trump-linked crypto venture Alt5 Sigma retains auditor - FT
Brief: ALT5 Sigma Corporation Provides Corporate Update
American Bitcoin steadies after share lock-up expiry sparks near 40% plunge (updated)